PolyPid
PYPD
8 hedge funds and large institutions have $5.13M invested in PolyPid in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
6,349% more capital invested
Capital invested by funds: $79.6K → $5.13M (+$5.05M)
60% more funds holding
Funds holding: 5 → 8 (+3)
21.65% more ownership
Funds ownership: 1.28% → 22.92% (+22%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.9M |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$2.51M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.5K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.01K |
PYPD Hedge Fund Activity: Q1 2024 in Review
8 of the 6,960 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q1 2024, worth a combined $5.13M — up 6,349% from $79.6K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PYPD positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $2.9M. The largest seller was UBS Group, cutting an estimated $4.5K.
- 8 institutional investors held PolyPid (PYPD) as of Q1 2024, up from 5 in Q4 2023.
- Funds reported $5.13M of PolyPid stock for Q1 2024, up 6,349% quarter-over-quarter.
- 3 funds opened new PolyPid positions in Q1 2024 and 0 closed out, a net change of +3 holders.
- The largest PolyPid buyer in Q1 2024 was AIGH Capital Management, an estimated $2.9M added.
- The largest PolyPid seller in Q1 2024 was UBS Group, an estimated $4.5K sold.
Based on aggregated 13F filings for Q1 2024.